Clinical Trials Directory

Trials / Completed

CompletedNCT01367080

A Study to Compare the Pharmacokinetic Profiles of Etravil® Tablet 10mg and Etravil® Tablet 25mg

Clinical Trials to Compare the Pharmacokinetics Profile of Etravil®(Amitriptyline Hydrochloride) Tablet 10mg and Etravil®(Amitriptyline Hydrochloride) Tablet 25mg After a Single Oral Administration in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Dong Wha Pharmaceutical Co. Ltd. · Industry
Sex
Male
Age
19 Years – 50 Years
Healthy volunteers
Accepted

Summary

To evaluate the pharmacokinetics of single oral dose of Amitriptyline hydrochloride film-coated tablet 10mg \& 25mg

Detailed description

Randomized, Single dose, 2-way crossover, Open Study to compare the pharmacokinetics profile of Etravil®(Amitriptyline Hydrochloride) Tablet 10mg and Etravil®(Amitriptyline Hydrochloride) Tablet 25mg after a single oral administration in healthy male volunteers

Conditions

Interventions

TypeNameDescription
DRUGDWETR10Amitriptyline hydrochloride 10mg(DWETR10) single dose
DRUGDWETR25Amitriptyline hydrochloride 25mg(DWETR25) single dose

Timeline

Start date
2011-07-01
Primary completion
2011-08-01
Completion
2011-09-01
First posted
2011-06-06
Last updated
2014-08-22
Results posted
2014-08-22

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01367080. Inclusion in this directory is not an endorsement.